Literature DB >> 20585811

Gastroesophageal reflux disease.

Kwong Ming Fock1, Choo Hean Poh.   

Abstract

GERD is a common chronic gastrointestinal disorder, and its prevalence in Asia is increasing. Classical symptoms of heartburn and regurgitation are common presentations. There is no standard criterion for the diagnosis of GERD, and 24-h pH monitoring lacks sensitivity in NERD. Furthermore, diagnostic studies for gastroesophageal reflux disease have several limitations. A short course of PPI is often used in clinical practice as a diagnostic test for gastroesophageal reflux disease. Elderly patients with GERD usually present with atypical manifestations, and they tend to develop more severe disease. PPI remains the mainstay of treatment for GERD. In a subset of patients who wish to discontinue maintenance treatment, anti-reflux surgery is a therapeutic option.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20585811     DOI: 10.1007/s00535-010-0274-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  63 in total

1.  Non-erosive reflux disease (NERD)--acid reflux and symptom patterns.

Authors:  S D Martinez; I B Malagon; H S Garewal; H Cui; R Fass
Journal:  Aliment Pharmacol Ther       Date:  2003-02-15       Impact factor: 8.171

2.  Lugol chromoendoscopy as a diagnostic tool in so-called endoscopy-negative GERD.

Authors:  Ichiro Yoshikawa; Masahiro Yamasaki; Takuji Yamasaki; Keiichiro Kume; Makoto Otsuki
Journal:  Gastrointest Endosc       Date:  2005-11       Impact factor: 9.427

3.  Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo).

Authors:  S Bruley des Varannes; F Mion; P Ducrotté; F Zerbib; P Denis; T Ponchon; R Thibault; J P Galmiche
Journal:  Gut       Date:  2005-04-20       Impact factor: 23.059

4.  The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis.

Authors:  R Fass; J J Ofman; R E Sampliner; L Camargo; C Wendel; M B Fennerty
Journal:  Aliment Pharmacol Ther       Date:  2000-04       Impact factor: 8.171

5.  Validation of a graded response questionnaire for the diagnosis of gastroesophageal reflux disease in an Asian primary care population.

Authors:  Khek Yu Ho; Kok Ann Gwee; Jen Lock Khor; Dede Sutedja Selamat; Khay Guan Yeoh
Journal:  J Clin Gastroenterol       Date:  2008-07       Impact factor: 3.062

6.  Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group.

Authors:  S J Spechler
Journal:  N Engl J Med       Date:  1992-03-19       Impact factor: 91.245

7.  Prevalence of gastroesophageal reflux in elderly patients in a primary care setting.

Authors:  J W Mold; L E Reed; A B Davis; M L Allen; D L Decktor; M Robinson
Journal:  Am J Gastroenterol       Date:  1991-08       Impact factor: 10.864

8.  Asia-Pacific consensus on the management of gastroesophageal reflux disease: update.

Authors:  Kwong Ming Fock; Nicholas J Talley; Ronnie Fass; Khean Lee Goh; Peter Katelaris; Richard Hunt; Michio Hongo; Tiing Leong Ang; Gerald Holtmann; Sanjay Nandurkar; San Ren Lin; Benjamin C Y Wong; Francis K L Chan; Abdul Aziz Rani; Young-Tae Bak; Jose Sollano; Khek Yu Ho; Lawrence K Y Ho; Sathoporn Manatsathit
Journal:  J Gastroenterol Hepatol       Date:  2008-01       Impact factor: 4.029

Review 9.  Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease.

Authors:  Kwong Ming Fock; Nick Talley; Richard Hunt; Ronnie Fass; Sanjay Nandurkar; Shiu-Kum Lam; Khean Lee Goh; Jose Sollano
Journal:  J Gastroenterol Hepatol       Date:  2004-04       Impact factor: 4.029

Review 10.  The role and limitations of H2-receptor antagonists in the treatment of gastro-oesophageal reflux disease.

Authors:  D G Colin-Jones
Journal:  Aliment Pharmacol Ther       Date:  1995       Impact factor: 8.171

View more
  3 in total

1.  Protease-Activated Receptor-2 Up-Regulates Transient Receptor Potential Vanilloid 4 Function in Mouse Esophageal Keratinocyte.

Authors:  Nobuhiro Suzuki; Hiroshi Mihara; Hirofumi Nishizono; Makoto Tominaga; Toshiro Sugiyama
Journal:  Dig Dis Sci       Date:  2015-08-02       Impact factor: 3.199

Review 2.  The management of gastro-oesophageal reflux disease.

Authors:  Charlotte Keung; Geoffrey Hebbard
Journal:  Aust Prescr       Date:  2016-02-01

3.  The Diagnostic Significance of Coapplying a Rabeprazole Test with the SF-36 for Gastroesophageal Reflux Disease.

Authors:  Ying Chen; Feng Wang; Yuanxi Jiang; Chen Wang; Liwen Yao; Ping Wu; Yili Tong; Huihui Sun; Shuchang Xu
Journal:  Gastroenterol Res Pract       Date:  2013-02-28       Impact factor: 2.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.